We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Spinal Anesthesia Superior for Hip Fracture Surgery

By HospiMedica International staff writers
Posted on 30 Apr 2018
A new study suggests a strong association between spinal anesthesia (SA) and reduced mortality in elderly patients undergoing hip fracture fixation surgery.

Researchers at the University of Toronto (Canada) and Toronto Western Hospital (Canada) conducted a study of all patients who underwent hip fracture fixation between 2003 and 2015. More...
The researchers then matched 883 patient cohorts for 29 variables known to affect mortality and morbidity associated with hip fractures. They then matched the patients who received SA with those who received general anesthesia (GA). The main outcome was impact of SA on 90-day mortality.

The results revealed that patients who received SA were more likely to be male, elderly, have a higher ASA score, and receive earlier hip fracture fixation; and less likely to have metastatic cancer and take calcium channel blockers. Overall, 90-day mortality was significantly lower in patients who received SA (6.3%) than in GA patients (8.8%), a relative risk reduction of 26.1%. The SA patients also had fewer blood clots in the lungs, lower rates of major blood loss, and shorter hospital stays. The study was presented at the 2018 World Congress on Regional Anesthesia and Pain Medicine, held during April 2018 in New York (NY, USA).

“A strong association was identified between spinal anesthesia and lower 90-day mortality post hip fracture repair. Overall, patients who received spinal anesthesia were less likely to die from a cardiac event, but more likely to die from a respiratory cause or sepsis,” concluded lead author Sarah Tierney, MD, of the University of Toronto. “There was no between-group difference noted in hospital length of stay or major cardiac events.”

SA involves injection of a local anesthetic into the subarachnoid space, generally through a fine needle, in order to block the transmission of afferent nerve signals from peripheral nociceptors. The degree of neuronal blockade depends on the amount and concentration of anesthetic used, and the properties of the axon. As such, thin unmyelinated C-fibers associated with pain are blocked first, while thick, heavily myelinated A-alpha motor neurons are blocked moderately. SA is not to be confused with an epidural, whereby a local anesthetic drug is injected through a catheter placed into the epidural space.

Related Links:
University of Toronto
Toronto Western Hospital


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Pediatric Mask
Respire SOFT
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.